In a group of patients with coronary artery disease (CAD), it was shown that higher levels of PTX3 correlate with more advanced CAD and could be postulated as a biomarker of cardiovascular risk before the increase in CRP [30]. This evidence concerns the gene PTX3 and coronary artery disorder.